跳至主要内容
临床试验/EUCTR2017-000994-35-ES
EUCTR2017-000994-35-ES进行中(未招募)1 期

Study of tolerability of iron liposome compared to ferrous sulphate in pregnant women with iron deficiency anemia.

Hospital General Universitario de Alicante0 个研究点目标入组 130 人开始时间: 2017年12月21日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • -Pregnant women diagnosed with iron deficiency anemia in second trimester analysis (week 24-28), understood as hemoglobin <11 g / dL, serum ferritin <12 and hematocrit <33%.
  • -Pregnant women aged 18 or over.
  • - Single pregnancy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 130
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • · Anemia from other causes.
  • · Blood transfusion, treatment with oral or intravenous iron one month prior to analytical analysis of the second quarter.
  • · Chronic maternal medical pathology prior to gestation (clinical and/or analitic evidence of hepatic, renal, pulmonary, haematological or cardiovascular abnormalities, history of peptic ulcer
  • Women with dietary restrictions (allergies or food intolerances). Women with specific dietary patterns (vegetarian or vegan).
  • Hypersensitivity to iron supplements.
  • Lactose intolerance.
  • Severe anemia: hemoglobin <9 g/dl
  • · Fetal pathology: chromosomal abnormalities or fetal malformations on ultrasound.

研究者

发起方
Hospital General Universitario de Alicante

相似试验